Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.19.3.a.u2
Stock-Based Compensation - Liberty - Outstanding Awards (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Additional disclosures      
Total unrecognized compensation cost related to unvested equity awards $ 34    
Weighted average period of recognition related to unvested equity awards (in years) 2 years 1 month 6 days    
Options, exercises in period, total intrinsic value $ 163 $ 22 $ 31
Common Class B      
Number of options      
Outstanding at end of period 0    
Restricted Stock      
Additional disclosures      
Equity instruments other than options, vested in period, fair value $ 17 $ 9 $ 85
Liberty Sirius XM Group      
Additional disclosures      
Common stock reserved for issuance 9,800,000    
Liberty Sirius XM Group | Common Class A      
Number of options      
Outstanding at beginning of period 1,403,000    
Exercised (1,381,000)    
Outstanding at end of period 22,000 1,403,000  
Exercisable at end of period 22,000    
WAEP      
Outstanding at beginning of period $ 19.84    
Exercised 19.79    
Outstanding at end of period 22.62 $ 19.84  
Exercisable at end of period $ 22.62    
Additional disclosures      
Weighted average remaining life, outstanding 4 months 24 days    
Weighted average remaining life, exercisable 4 months 24 days    
Aggregate intrinsic value, outstanding $ 1    
Aggregate intrinsic value, exercisable $ 1    
Liberty Sirius XM Group | Common Class C      
Number of options      
Outstanding at beginning of period 11,495,000    
Granted 1,598,000    
Exercised (2,923,000)    
Forfeited/Cancelled (353,000)    
Outstanding at end of period 9,817,000 11,495,000  
Exercisable at end of period 7,997,000    
WAEP      
Outstanding at beginning of period $ 28.85    
Granted 45.08    
Exercised 20.42    
Forfeited/Cancelled 31.69    
Outstanding at end of period 33.90 $ 28.85  
Exercisable at end of period $ 32.18    
Additional disclosures      
Weighted average remaining life, outstanding 3 years 7 months 6 days    
Weighted average remaining life, exercisable 3 years 2 months 12 days    
Aggregate intrinsic value, outstanding $ 140    
Aggregate intrinsic value, exercisable $ 128    
Liberty Sirius XM Group | Restricted Stock      
Additional disclosures      
Equity instruments other than options, nonvested, number 94,000    
Restricted stock weighted average grant-date fair value $ 36.07    
Formula One Group      
Additional disclosures      
Common stock reserved for issuance 8,300,000    
Formula One Group | Common Class A      
Number of options      
Outstanding at beginning of period 360,000    
Exercised (359,000)    
Outstanding at end of period 1,000 360,000  
Exercisable at end of period 1,000    
WAEP      
Outstanding at beginning of period $ 11.71    
Exercised 11.71    
Outstanding at end of period 12.63 $ 11.71  
Exercisable at end of period $ 12.63    
Additional disclosures      
Weighted average remaining life, outstanding 3 years    
Weighted average remaining life, exercisable 3 years    
Formula One Group | Common Class C      
Number of options      
Outstanding at beginning of period 6,684,000    
Granted 2,959,000    
Exercised (1,273,000)    
Forfeited/Cancelled (86,000)    
Outstanding at end of period 8,284,000 6,684,000  
Exercisable at end of period 6,427,000    
WAEP      
Outstanding at beginning of period $ 26.92    
Granted 36.38    
Exercised 21.80    
Forfeited/Cancelled 19.26    
Outstanding at end of period 31.16 $ 26.92  
Exercisable at end of period $ 29.61    
Additional disclosures      
Weighted average remaining life, outstanding 4 years 10 months 24 days    
Weighted average remaining life, exercisable 4 years 6 months    
Aggregate intrinsic value, outstanding $ 123    
Aggregate intrinsic value, exercisable $ 105    
Formula One Group | Restricted Stock      
Additional disclosures      
Equity instruments other than options, nonvested, number 149,000    
Restricted stock weighted average grant-date fair value $ 34.03    
Braves Group      
Additional disclosures      
Common stock reserved for issuance 1,300,000    
Braves Group | Common Class A      
Number of options      
Outstanding at beginning of period 177,000    
Exercised (175,000)    
Outstanding at end of period 2,000 177,000  
Exercisable at end of period 2,000    
WAEP      
Outstanding at beginning of period $ 11.44    
Exercised 11.43    
Outstanding at end of period 11.89 $ 11.44  
Exercisable at end of period $ 11.89    
Additional disclosures      
Weighted average remaining life, outstanding 2 years 6 months    
Weighted average remaining life, exercisable 2 years 6 months    
Braves Group | Common Class C      
Number of options      
Outstanding at beginning of period 1,276,000    
Granted 382,000    
Exercised (358,000)    
Forfeited/Cancelled (33,000)    
Outstanding at end of period 1,267,000 1,276,000  
Exercisable at end of period 815,000    
WAEP      
Outstanding at beginning of period $ 16.58    
Granted 28.93    
Exercised 11.37    
Forfeited/Cancelled 15.19    
Outstanding at end of period 21.82 $ 16.58  
Exercisable at end of period $ 18.81    
Additional disclosures      
Weighted average remaining life, outstanding 4 years 3 months 18 days    
Weighted average remaining life, exercisable 3 years 1 month 6 days    
Aggregate intrinsic value, outstanding $ 10    
Aggregate intrinsic value, exercisable $ 9    
Braves Group | Restricted Stock      
Additional disclosures      
Equity instruments other than options, nonvested, number 73,000    
Restricted stock weighted average grant-date fair value $ 27.31